{"id":"W4306252831","doi":"10.1093/eurheartj/ehac544.1233","title":"Longer-term safety of alirocumab with 24,610 patient-years of placebo-controlled observation: further insights from the ODYSSEY OUTCOMES trial","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Alirocumab; Medicine; PCSK9; Internal medicine; Post-hoc analysis; Unstable angina; Placebo; Myocardial infarction; Mace; Evolocumab; Acute coronary syndrome; Cholesterol; Lipoprotein; Percutaneous coronary intervention","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01417146,0.0006645258,0.002196536,0.0002989928,0.0005583099,0.001623461,0.0007073241,0.001440792,0.002844961],"category_scores_gemma":[0.01286624,0.000245552,0.002488039,0.0007549303,0.0007804797,0.001628216,0.0009595444,0.001777513,0.000317855],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007182714,"about_ca_system_score_gemma":0.0009614721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006864484,"about_ca_topic_score_gemma":0.0008442309,"domain_scores_codex":[0.9930909,0.004568683,0.0004916172,0.0008844604,0.0004923581,0.0004719387],"domain_scores_gemma":[0.9919669,0.002642986,0.002739586,0.001019731,0.0004946772,0.001136219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8966951,0.003820147,0.045981,0.0009780134,0.00727488,0.0001535086,0.0002678308,0.0007512755,0.001852826,0.0002952617,0.001335084,0.040595],"study_design_scores_gemma":[0.4192297,0.193351,0.360157,0.0004445356,0.01186059,0.0003718,0.0003564533,0.003021466,0.00143837,0.001446771,0.008152156,0.0001702403],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865865,0.009753731,0.0005881358,0.0004575254,0.0001293286,0.0003016556,0.000945139,0.00002039599,0.001217615],"genre_scores_gemma":[0.996082,0.001215125,0.0003038013,0.0003966017,0.0002625613,0.0003370429,0.001051598,0.000006939418,0.0003443278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01417146,"threshold_uncertainty_score":0.07494676,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03031792876812264,"score_gpt":0.2551177849852828,"score_spread":0.2247998562171601,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}